Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Handfield

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Cellular Microbiology|May 13, 2005
Distinct transcriptional profiles characterize oral epithelium-microbiota interactionsMartin Handfield, Jeffrey J Mans, Gaolin Zheng, et al.
Molecular Microbiology|June 6, 2003
Identification of Candida albicans genes induced during thrush offers insight into pathogenesisShaoji Cheng, Cornelius J Clancy, Mary Ann Checkley, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2003
Use of in vivo-induced antigen technology (IVIAT) to identify genes uniquely expressed during human infection with Vibrio choleraeLong Hang, Manohar John, Muhammad Asaduzzaman, et al.
Infection and Immunity|April 23, 2005
Use of in vivo-induced antigen technology for identification of Escherichia coli O157:H7 proteins expressed during human infectionManohar John, Indira T Kudva, Robert W Griffin, et al.
Infection and Immunity|September 23, 2003
Characterization and pathogenic significance of Vibrio vulnificus antigens preferentially expressed in septicemic patientsYoung Ran Kim, Shee Eun Lee, Choon Mee Kim, et al.
Plos One|March 20, 2008
Application of in vivo induced antigen technology (IVIAT) to Bacillus anthracisSean M Rollins, Amanda Peppercorn, John S Young, et al.
Infection and Immunity|August 24, 2006
Identification of in vivo-induced bacterial protein antigens during human infection with Salmonella enterica serovar TyphiJason B Harris, Andrea Baresch-Bernal, Sean M Rollins, et al.
Scientific Reports|June 13, 2022
Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamstersFelicity C Stark, Bassel Akache, Lise Deschatelets, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Cellular Microbiology|May 13, 2005
Distinct transcriptional profiles characterize oral epithelium-microbiota interactionsMartin Handfield, Jeffrey J Mans, Gaolin Zheng, et al.
Molecular Microbiology|June 6, 2003
Identification of Candida albicans genes induced during thrush offers insight into pathogenesisShaoji Cheng, Cornelius J Clancy, Mary Ann Checkley, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2003
Use of in vivo-induced antigen technology (IVIAT) to identify genes uniquely expressed during human infection with Vibrio choleraeLong Hang, Manohar John, Muhammad Asaduzzaman, et al.
Infection and Immunity|April 23, 2005
Use of in vivo-induced antigen technology for identification of Escherichia coli O157:H7 proteins expressed during human infectionManohar John, Indira T Kudva, Robert W Griffin, et al.
Infection and Immunity|September 23, 2003
Characterization and pathogenic significance of Vibrio vulnificus antigens preferentially expressed in septicemic patientsYoung Ran Kim, Shee Eun Lee, Choon Mee Kim, et al.
Plos One|March 20, 2008
Application of in vivo induced antigen technology (IVIAT) to Bacillus anthracisSean M Rollins, Amanda Peppercorn, John S Young, et al.
Infection and Immunity|August 24, 2006
Identification of in vivo-induced bacterial protein antigens during human infection with Salmonella enterica serovar TyphiJason B Harris, Andrea Baresch-Bernal, Sean M Rollins, et al.
Scientific Reports|June 13, 2022
Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamstersFelicity C Stark, Bassel Akache, Lise Deschatelets, et al.
Pageof 4